deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT00610935

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.

Sponsor: BioCryst Pharmaceuticals

Conditions Influenza
Updated 8 times since 2017 Last updated: Feb 24, 2021 Started: Jan 31, 2008 Primary completion: Feb 29, 2008 Completion: Feb 29, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This study was terminated for administrative reasons.

This PHASE3 trial investigates Influenza and is currently terminated or withdrawn. BioCryst Pharmaceuticals leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotTerminated~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Apr 2021 — Dec 2021 [monthly]

    Terminated PHASE3

  5. Jan 2021 — Apr 2021 [monthly]

    Terminated PHASE3

Show 3 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BioCryst Pharmaceuticals
Data source: BioCryst Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .